Gennex Laboratories Ltd.

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals

17.21

-0.27 (-1.54%)

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals

NSE BSE

Sector Pharmaceuticals & Biotechnology
Industry Pharmaceuticals

17.21

-0.27 (-1.54%)
16:01 Dec 20

Quality

52/100
Medium Financial Strength

Valuation

55/100
Affordable Valuation

Technical

45/100
Technically Neutral

Strength

Weakness

Opportunity

Threats

ROE %

ROA %

EPS

BVPS

Net Profit Margin

Income Statement Balance sheet Cash flow Ratio Shareholding

Quarterly Annual

Consolidated Standalone

	Mar 2021	Mar 2022	Mar 2023	Mar 2024	TTM 2024
Net Sales	59.65	61.21	65.6	86.71	112.51
Operating Expenses +	53.12	55.83	60.91	69.68	95.88
Raw Material	34.19	40.01	46.91	57.88	78.44
Increase Decrease in Cost	1.53	-1.91	-7	-9.03	-4.77
Other Manufacturing Expense	0	0	0	0	0
Employee Cost	7.21	6.97	7.87	7.79	7.22
Miscellaneous Expenses	10.19	10.76	13.13	13.04	14.99
Operating Profit	6.53	5.38	4.69	17.03	16.63
Other Income	0.52	1.38	3.95	4.91	8.56
Depreciation	0.88	0.79	0.92	2.37	1.35
Interest	0.74	0.88	1.35	3.08	3.4
Profit before tax and exceptio..	5.43	5.09	6.37	16.49	20.44
Exceptional Items	-0.37	0	0	0	0
PBT	5.06	5.09	6.37	16.49	20.44
Provision for Taxation	1.02	1.17	1.45	3.32	3.16
Net Profit	4.04	3.92	4.92	13.18	17.29
NET Profit after MI	4.04	3.92	4.92	13.18	16.75
EPS	0.32	0.33	0.42	0.66	0.74
Operating Profit Margin (%)	10.95	8.79	7.15	19.64	14.78
Net Profit Margin (%)	6.77	6.4	7.5	15.2	14.89

ShareHolding

All Data in Percentage (%)

	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23
Promoter	18.40	18.40	18.40	23.60	23.60
FII	0.00	0.00	0.00	0.00	0.00
MF	0.00	0.00	0.00	0.00	0.00
Public	81.60	81.60	81.60	76.40	76.40
Others	0.00	0.00	0.00	0.00	0.00
Others	0.00	0.00	0.00	0.00	0.00